BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang J, Liu X, Cao S, Dong X, Rao S, Cai K. Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade. Front Oncol 2020;10:1727. [PMID: 33014854 DOI: 10.3389/fonc.2020.01727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Niu R, Zhao F, Dong Z, Li Z, Li S. A stratification system of ferroptosis and iron-metabolism related LncRNAs guides the prediction of the survival of patients with esophageal squamous cell carcinoma. Front Oncol 2022;12:1010074. [DOI: 10.3389/fonc.2022.1010074] [Reference Citation Analysis]
2 Zhang J, Zhang N, Yang X, Xin X, Jia C, Li S, Lu Q, Jiang T, Wang T, Shi Z. Machine Learning and Novel Biomarkers Associated with Immune Infiltration for the Diagnosis of Esophageal Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/6732780] [Reference Citation Analysis]
3 Wang Z, Wu S, Zhu C, Shen J. The role of ferroptosis in esophageal cancer. Cancer Cell Int 2022;22:266. [PMID: 35999642 DOI: 10.1186/s12935-022-02685-w] [Reference Citation Analysis]
4 Mitra S, Das R, Emran TB, Labib RK, Noor-e-tabassum, Islam F, Sharma R, Ahmad I, Nainu F, Chidambaram K, Alhumaydhi FA, Chandran D, Capasso R, Wilairatana P. Diallyl Disulfide: A Bioactive Garlic Compound with Anticancer Potential. Front Pharmacol 2022;13:943967. [DOI: 10.3389/fphar.2022.943967] [Reference Citation Analysis]
5 Ronco AL, Martínez-López W, Calderón JM, Storz MA. Dietary acid load and esophageal cancer risk: A case-control study. Thorac Cancer 2022. [PMID: 36054595 DOI: 10.1111/1759-7714.14612] [Reference Citation Analysis]
6 Hu H, Zhang J, Yan H, Qin C, Guo H, Liu T, Tang S, Zhou H. Development and validation of a novel prognostic model for patients with surgically resected esophageal squamous cell carcinoma. Front Oncol 2022;12:955353. [DOI: 10.3389/fonc.2022.955353] [Reference Citation Analysis]
7 Geng X, Liu J, Sun H, Song Z, Qin S, Li Y, Zhang Y, Hao F, Cai Y. Subcutaneous soft tissue metastases from esophageal squamous cell carcinoma with neuroendocrine differentiation: Case report and literature review. Front Oncol 2022;12:895189. [DOI: 10.3389/fonc.2022.895189] [Reference Citation Analysis]
8 Liu L, Cheng H, Ji M, Su L, Lu Z, Hu X, Guan Y, Xiao J, Ma L, Zhang W, Pu H. OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma. Biol Proced Online 2022;24:10. [PMID: 35850645 DOI: 10.1186/s12575-022-00169-9] [Reference Citation Analysis]
9 Zhao F, Dong Z, Li Y, Liu S, Guo P, Zhang D, Li S. Comprehensive Analysis of Molecular Clusters and Prognostic Signature Based on m7G-related LncRNAs in Esophageal Squamous Cell Carcinoma. Front Oncol 2022;12:893186. [DOI: 10.3389/fonc.2022.893186] [Reference Citation Analysis]
10 Nilsson M, Olafsdottir H, Alexandersson von Döbeln G, Villegas F, Gagliardi G, Hellström M, Wang Q, Johansson H, Gebski V, Hedberg J, Klevebro F, Markar S, Smyth E, Lagergren P, Al-haidari G, Rekstad LC, Aahlin EK, Wallner B, Edholm D, Johansson J, Szabo E, Reynolds JV, Pramesh C, Mummudi N, Joshi A, Ferri L, Wong RK, O’callaghan C, Lukovic J, Chan KK, Leong T, Barbour A, Smithers M, Li Y, Kang X, Kong F, Chao Y, Crosby T, Bruns C, van Laarhoven H, van Berge Henegouwen M, van Hillegersberg R, Rosati R, Piessen G, de Manzoni G, Lordick F. Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial. Front Oncol 2022;12:917961. [DOI: 10.3389/fonc.2022.917961] [Reference Citation Analysis]
11 Zhao F, Li Z, Dong Z, Wang Z, Guo P, Zhang D, Li S. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma. Front Immunol 2022;13:918154. [DOI: 10.3389/fimmu.2022.918154] [Reference Citation Analysis]
12 Yin GQ, Li ZL, Li D. The Safety and Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study. Cancer Manag Res 2022;14:2133-41. [PMID: 35795828 DOI: 10.2147/CMAR.S358620] [Reference Citation Analysis]
13 Qian CJ, Tong YY, Wu LK, Wang YC, Teng XS, Yao J. Circ_0000705 facilitates proline metabolism of esophageal squamous cell carcinoma cells by targeting miR-621/PYCR1 axis. Discov Oncol 2022;13:50. [PMID: 35731336 DOI: 10.1007/s12672-022-00513-1] [Reference Citation Analysis]
14 Dai D, Tian Q, Yu G, Shui Y, Jiang H, Wei Q. Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis. Cancers (Basel) 2022;14:3024. [PMID: 35740689 DOI: 10.3390/cancers14123024] [Reference Citation Analysis]
15 Liu C, Li X, Xiong F, Wang L, Chen K, Wu P, Hua L, Zhang Z. Down-regulation of MLLT1 super elongation complex subunit impairs the anti-tumor activity of natural killer cells in esophageal cancer. Immunobiology 2022;227:152238. [PMID: 35763909 DOI: 10.1016/j.imbio.2022.152238] [Reference Citation Analysis]
16 Zhao F, Li Y, Dong Z, Zhang D, Guo P, Li Z, Li S. Identification of A Risk Signature Based on Lactic Acid Metabolism-Related LncRNAs in Patients With Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2022;10:845293. [DOI: 10.3389/fcell.2022.845293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Weidle UH, Sela T, Brinkmann U, Niewoehner J. Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma. Cancer Genomics Proteomics 2022;19:283-98. [PMID: 35430563 DOI: 10.21873/cgp.20320] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Haddad R, Zlotnik O, Goshen-lago T, Levi M, Brook E, Brenner B, Kundel Y, Ben-aharon I, Kashtan H. Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma. JPM 2022;12:627. [DOI: 10.3390/jpm12040627] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhao F, Gao S, Qin X, Niu R, Li Z, Wang C, Li S. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2022;10:820870. [DOI: 10.3389/fcell.2022.820870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Mao J, Lu Q, Jing P, Li Z, Yang X, Zhang J, Li Z, Wang F. Comprehensive Analysis of Prognostic Value and Immune Infiltration of MMP12 in Esophageal Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/4097428] [Reference Citation Analysis]
21 Hu W, Yu J, Yao N, Li X, Yang Y, Wang L, Sun M, Guo Y, Wang H, Yan S, Li B. Efficacy and Safety of Four Different Endoscopic Treatments for Early Esophageal Cancer: a Network Meta-analysis. J Gastrointest Surg 2022. [PMID: 35194712 DOI: 10.1007/s11605-022-05276-2] [Reference Citation Analysis]
22 Pang M, Xie X, Zhang Y, Laster KV, Liu K, Kim DJ. Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway. Front Oncol 2021;11:780011. [PMID: 35155187 DOI: 10.3389/fonc.2021.780011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Muruganantham B, Sivamaruthi BS, Kesika P, Thangaleela S, Chaiyasut C. Bioinformatics Characterization of Candidate Genes Associated with Gene Network and miRNA Regulation in Esophageal Squamous Cell Carcinoma Patients. Applied Sciences 2022;12:1083. [DOI: 10.3390/app12031083] [Reference Citation Analysis]
24 Ma Y, Yao X, Li Z, Chen J, Li W, Wang H, Zhang L, Zhu J. The role of vascular invasion and lymphatic invasion in predicting recurrent thoracic oesophageal squamous cell carcinoma. World J Surg Oncol 2022;20:12. [PMID: 35012555 DOI: 10.1186/s12957-021-02458-1] [Reference Citation Analysis]
25 Jia Y, Tian C, Wang H, Yu F, Lv W, Duan Y, Cheng Z, Wang X, Wang Y, Liu T, Wang J, Liu L. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin. Mol Cancer 2021;20:162. [PMID: 34893064 DOI: 10.1186/s12943-021-01455-y] [Reference Citation Analysis]
26 Cai S, Fan Y, Guo Q, Sun Y, Zhao P, Tian Y, Fan Q. Impact of Radiation Dose to Circulating Immune Cells on Tumor Control and Survival in Esophageal Cancer. Cancer Biother Radiopharm 2021. [PMID: 34883023 DOI: 10.1089/cbr.2021.0250] [Reference Citation Analysis]
27 Zhu X, Chen D, Li S, Zhang W, Li Y, Wang X, Zhou J, Wen Z. Albumin-To-Alkaline Phosphatase Ratio as a Novel and Promising Prognostic Biomarker in Patients Undergoing Esophagectomy for Carcinoma: A Propensity Score Matching Study. Front Oncol 2021;11:764076. [PMID: 34746006 DOI: 10.3389/fonc.2021.764076] [Reference Citation Analysis]
28 Wang H, Lin Z, Lin Y, Huang R, Qiu M, Peng X, He F, Huang L, Xiang Z, Lu W, Yan S, Liu S, Yang H, Zhang Z, Hu Z. Optimal Size Criterion for Malignant Lymph Nodes and a Novel Lymph Node Clinical Staging System for Unresectable Esophageal Squamous Cell Carcinoma: Evaluation by Multislice Spiral Computed Tomography. J Cancer 2021;12:6454-64. [PMID: 34659536 DOI: 10.7150/jca.61994] [Reference Citation Analysis]
29 Zheng Z, Zhang B, Yu H, Li S, Song N, Jin X, Li J. UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185. Int J Biol Sci 2021;17:3024-35. [PMID: 34421347 DOI: 10.7150/ijbs.61117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Wen L, Mao W, Xu L, Cai B, Gu L. Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling. Chem Biol Drug Des 2021. [PMID: 34411455 DOI: 10.1111/cbdd.13937] [Reference Citation Analysis]
31 Wang YM, Xu X, Tang J, Sun ZY, Fu YJ, Zhao XJ, Ma XM, Ye Q. Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α-AKT-mTOR pathway in esophageal squamous cell carcinoma. Cell Biosci 2021;11:124. [PMID: 34229754 DOI: 10.1186/s13578-021-00640-2] [Reference Citation Analysis]
32 Du W, Gao A, Herman JG, Wang L, Zhang L, Jiao S, Guo M. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer. Cancer Sci 2021;112:2870-83. [PMID: 33931924 DOI: 10.1111/cas.14917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lu T, Xu R, Li Q, Zhao JY, Peng B, Zhang H, Guo JD, Zhang SQ, Li HW, Wang J, Zhang LY. Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma. Mol Ther Oncolytics 2021;21:134-43. [PMID: 33981829 DOI: 10.1016/j.omto.2021.02.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]